DK81095A - Peroralt MR-kontraststof til lever og øvre tarmkanal - Google Patents

Peroralt MR-kontraststof til lever og øvre tarmkanal Download PDF

Info

Publication number
DK81095A
DK81095A DK081095A DK81095A DK81095A DK 81095 A DK81095 A DK 81095A DK 081095 A DK081095 A DK 081095A DK 81095 A DK81095 A DK 81095A DK 81095 A DK81095 A DK 81095A
Authority
DK
Denmark
Prior art keywords
liver
oral
contrast agent
intestinal tract
upper intestinal
Prior art date
Application number
DK081095A
Other languages
English (en)
Inventor
Henrik S Thomsen
Original Assignee
Henrik S Thomsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henrik S Thomsen filed Critical Henrik S Thomsen
Priority to DK081095A priority Critical patent/DK81095A/da
Priority to US08/677,051 priority patent/US6015545A/en
Priority to PCT/DK1996/000315 priority patent/WO1997002842A1/en
Priority to JP50543497A priority patent/JP4138875B2/ja
Priority to AU64139/96A priority patent/AU6413996A/en
Priority to EP03013794A priority patent/EP1350524A1/en
Priority to EP96923875A priority patent/EP0839057A1/en
Publication of DK81095A publication Critical patent/DK81095A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK081095A 1995-07-11 1995-07-11 Peroralt MR-kontraststof til lever og øvre tarmkanal DK81095A (da)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DK081095A DK81095A (da) 1995-07-11 1995-07-11 Peroralt MR-kontraststof til lever og øvre tarmkanal
US08/677,051 US6015545A (en) 1995-07-11 1996-07-09 Manganese containing magnetic resonance contrast agent
PCT/DK1996/000315 WO1997002842A1 (en) 1995-07-11 1996-07-10 Mr contrast agent
JP50543497A JP4138875B2 (ja) 1995-07-11 1996-07-10 Mr造影剤
AU64139/96A AU6413996A (en) 1995-07-11 1996-07-10 Mr contrast agent
EP03013794A EP1350524A1 (en) 1995-07-11 1996-07-10 A MRI contrast medium composition
EP96923875A EP0839057A1 (en) 1995-07-11 1996-07-10 Mr contrast agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK081095A DK81095A (da) 1995-07-11 1995-07-11 Peroralt MR-kontraststof til lever og øvre tarmkanal

Publications (1)

Publication Number Publication Date
DK81095A true DK81095A (da) 1997-01-12

Family

ID=8097839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK081095A DK81095A (da) 1995-07-11 1995-07-11 Peroralt MR-kontraststof til lever og øvre tarmkanal

Country Status (6)

Country Link
US (1) US6015545A (da)
EP (2) EP0839057A1 (da)
JP (1) JP4138875B2 (da)
AU (1) AU6413996A (da)
DK (1) DK81095A (da)
WO (1) WO1997002842A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
GB9619759D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
EP1105162A1 (en) * 1998-08-10 2001-06-13 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
HUP0202238A3 (en) * 1999-07-12 2004-05-28 Idec Pharmaceuticals Inc San D Blocking immune response to a foreign antigen using an antagonist which binds to cd20
EP1474396B9 (en) 2002-02-05 2008-07-09 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
US7623903B2 (en) * 2002-05-17 2009-11-24 Wacker Frank K Double contrast technique for MRI-guided vascular interventions
SE527491C2 (sv) * 2003-12-19 2006-03-21 Cmc Contrast Ab Kontraktsmedelskomposition för magnetisk resonanstomografi för oral administration
WO2010099804A1 (en) * 2009-03-05 2010-09-10 Cmc Contrast Ab Magnetic resonance imaging of the liver
WO2011003818A2 (en) 2009-07-06 2011-01-13 Cmc Contrast Ab Diagnostic method
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
KR20220018498A (ko) * 2019-06-07 2022-02-15 아실리아 파마 아베 Mri용 압축 고체 조성물
US12514482B2 (en) * 2020-09-14 2026-01-06 Biosense Webster (Israel) Ltd. Identification of ablation gaps

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
US4863898A (en) * 1986-02-06 1989-09-05 Albion International, Inc. Amino acid chelated compositions for delivery to specific biological tissue sites
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
DK531488A (da) * 1987-09-25 1989-03-26 Salutar Inc Nmr-billeddannelse med mn(ii)-koordinationsforbindelser
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
US5064636A (en) * 1989-10-19 1991-11-12 Li King C P Paramagnetic oil emulsions as enteric MRI contrast agents
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US5215750A (en) * 1991-09-04 1993-06-01 Keane Ii Michael A L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control
JP2911674B2 (ja) * 1992-02-20 1999-06-23 明治乳業株式会社 消化管造影用組成物
US5292729A (en) * 1992-08-14 1994-03-08 Albion International, Inc. II-bond aromatic vitamin chelates
US5422127A (en) * 1992-12-21 1995-06-06 Bristol-Myers Squibb Company Nutritional compositions containing vitamin D esters
US5340603A (en) * 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
IT1265440B1 (it) * 1993-12-24 1996-11-22 Bracco Spa Formulazioni diagnostiche paramagnetiche e metodo d'uso delle stesse
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions

Also Published As

Publication number Publication date
JPH11508594A (ja) 1999-07-27
US6015545A (en) 2000-01-18
JP4138875B2 (ja) 2008-08-27
AU6413996A (en) 1997-02-10
EP1350524A1 (en) 2003-10-08
WO1997002842A1 (en) 1997-01-30
EP0839057A1 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
NO20002566D0 (no) System og fremgangsmÕte for datamaskinbasert tvistløsning
NO20014219L (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO982817L (no) FremgangsmÕte og innretning for intravaskulµr ultralydavbildning
NO20000932D0 (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
NO974494D0 (no) Radiomerkede peptider for diagnostikk og terapi
IS5794A (is) Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil
NO20004741D0 (no) Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode
DK81095A (da) Peroralt MR-kontraststof til lever og øvre tarmkanal
NO20010260L (no) Tarmbeskyttelsesbelagt farmasøytisk tablett og fremgangsmÕte for fremstilling
NO972125L (no) Hemorroideblandinger og fremgangsmåte for anvendelse
NO307182B1 (no) Farmasoeytiske blandinger og tricykliske forbindelser
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
IS4615A (is) Mótefnavakar Helicobacter pylori og bóluefnablöndur
NO972578D0 (no) Fremgangsmåte og anordning for forsegling
NO964907D0 (no) Anordning for innspilling og avspilling
NO982430D0 (no) FremgangsmÕte og anordning for drift av en kopling
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DK0879824T3 (da) Triterpenderivater og middel mod leversygdom
DK0889051T3 (da) Triterpenderivater og midler mod leversygdomme
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
DE69625576D1 (de) Entwicklungsvorrichtung und Bilderzeugungsgerät
NO994599D0 (no) Anordning og fremgangsmaate for prosodigenering av visuell syntese
EP0770400A3 (en) Labeled acyl-L-carnitine and diagnostic agents

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment